Whitehawk Therapeutics (WHWK) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.68% |
| Dec 31, 2025 | -16.23% |
| Sep 30, 2025 | 26.72% |
| Jun 30, 2025 | -39.61% |
| Mar 31, 2025 | 82.78% |
| Dec 31, 2024 | -43.95% |
| Sep 30, 2024 | -33.13% |
| Jun 30, 2024 | -30.99% |
| Mar 31, 2024 | -26.49% |
| Dec 31, 2023 | -23.36% |
| Sep 30, 2023 | -32.88% |
| Jun 30, 2023 | -24.95% |
| Mar 31, 2023 | -16.12% |
| Dec 31, 2022 | -15.85% |
| Sep 30, 2022 | -31.95% |
| Jun 30, 2022 | -32.88% |
| Mar 31, 2022 | 9.04% |
| Dec 31, 2021 | 28.19% |
| Sep 30, 2021 | -6.51% |
| Jun 30, 2021 | 37.52% |
| Mar 31, 2021 | 21.19% |
| Dec 31, 2020 | 214.36% |
| Sep 30, 2020 | -293.47% |
| Jun 30, 2020 | 175.99% |
| Mar 31, 2020 | -143.72% |
| Dec 31, 2019 | -61.54% |
| Sep 30, 2019 | -143.48% |
| Jun 30, 2019 | -151.53% |
| Mar 31, 2019 | -183.18% |
| Dec 31, 2018 | -83.84% |
| Sep 30, 2018 | 196.73% |
| Jun 30, 2018 | -176.97% |
| Mar 31, 2018 | -194.80% |
| Dec 31, 2017 | -87.22% |
| Sep 30, 2017 | -168.97% |
| Jun 30, 2017 | -178.18% |
| Mar 31, 2017 | -297.18% |
| Dec 31, 2016 | -243.18% |
| Sep 30, 2016 | -455.27% |
| Jun 30, 2016 | -441.59% |
| Mar 31, 2016 | -485.13% |
| Dec 31, 2015 | -45.20% |
| Sep 30, 2015 | -6.47% |